Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT04644237 · COMPLETED
Trial details
- NCT number
- NCT04644237
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-19
- Primary completion
- 2022-12-23
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.